Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Malignant Lymphoma

Free Subscription 26.08.2019 2 Am J Clin Pathol 1 Am J Hematol 5 Blood 1 BMC Neurol 2 Bone Marrow Transplant 2 Br J Haematol 1 Hum Pathol 1 J Laryngol Otol 3 Leuk Lymphoma 1 Leukemia 1 N Engl J Med 2 Oncol Rep 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Clin Pathol

1. VAN DER NEST BM, Leslie C, Joske D, Radeski D, et al
   Peripheral T-Cell Lymphoma Arising in Patients With Chronic Lymphocytic Leukemia.
   Am J Clin Pathol. 2019 Aug 21. pii: 5552737. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
2. ZHOU J, Hu L, Zuo M, Zhou Y, et al
   An Uncommon Case of Double-Hit Mantle Cell Lymphoma That Demonstrates a Transformation Process.
   Am J Clin Pathol. 2019 Aug 21. pii: 5552734. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   

   
   Am J Hematol

3. DEOL A, Uberti J
   Rapid and Sustained Response to CAR T Cell Therapy in Double Hit Diffuse Large B Cell Lymphoma.
   Am J Hematol. 2019 Aug 19. doi: 10.1002/ajh.25621.
   PubMed     Text format    
   
   

   
   Blood

4. AUSSEDAT G, Baseggio L
   One translocation for 2 lymphoid neoplasms.
   Blood. 2019;133:180.
   PubMed     Text format    
   
   
5. WANG HY, Hinds BR
   Cutaneous composite small lymphocytic lymphoma and primary cutaneous follicle center lymphoma.
   Blood. 2019;134:717.
   PubMed     Text format    
   
   
6. LI B, Yan J, Phyu T, Fan S, et al
   MELK mediates the stability of EZH2 through site-specific phosphorylation in extranodal natural killer/T-cell lymphoma.
   Blood. 2019 Aug 21. pii: blood.2019000381. doi: 10.1182/blood.2019000381.
   PubMed     Text format     Abstract available
   
   
7. BOJARCZUK K, Wienand K, Ryan JA, Chen L, et al
   Targeted inhibition of PI3Kalpha/delta is synergistic with BCL-2 blockade in genetically defined subtypes of DLBCL.
   Blood. 2019;133:70-80.
   PubMed     Text format     Abstract available
   
   
8. KUSUMOTO S, Arcaini L, Hong X, Jin J, et al
   Risk of HBV reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapy.
   Blood. 2018 Oct 19. pii: blood-2018-04-848044. doi: 10.1182/blood-2018-04-848044
   PubMed     Text format     Abstract available
   
   

   
   BMC Neurol

9. GUO R, Zhang X, Niu C, Xi Y, et al
   Primary central nervous system small lymphocytic lymphoma in the bilateral ventricles: two case reports.
   BMC Neurol. 2019;19:200.
   PubMed     Text format     Abstract available
   
   

   
   Bone Marrow Transplant

10. RIVAS MM, Berro M, Prates MV, Yantorno S, et al
    Allogeneic stem cell transplantation improves survival in relapsed Hodgkin lymphoma patients achieving complete remission after salvage treatment.
    Bone Marrow Transplant. 2019 Aug 21. pii: 10.1038/s41409-019-0640.
    PubMed     Text format     Abstract available
    
    
11. EINSELE H, Rasche L, Topp MS, Martin Kortum K, et al
    The use of bispecific antibodies to optimize the outcome of patients with acute leukemia, lymphoma and multiple myeloma after SCT.
    Bone Marrow Transplant. 2019;54.
    PubMed     Text format     Abstract available
    
    

    
    Br J Haematol

12. R WILSON M, McKay P, Leach M
    Primary leptomeningeal B-cell lymphoma.
    Br J Haematol. 2019 Aug 18. doi: 10.1111/bjh.16163.
    PubMed     Text format    
    
    
13. LOCKMER S, Ren W, Brodtkorb M, Ostenstad B, et al
    M7-FLIPI is not prognostic in follicular lymphoma patients with first-line rituximab chemo-free therapy.
    Br J Haematol. 2019 Aug 18. doi: 10.1111/bjh.16159.
    PubMed     Text format     Abstract available
    
    

    
    Hum Pathol

14. WANG JD, Katz SG, Morgan EA, Yang DT, et al
    Pro-apoptotic protein BIM as a novel prognostic marker in mantle cell lymphoma.
    Hum Pathol. 2019 Aug 16. pii: S0046-8177(19)30141.
    PubMed     Text format     Abstract available
    
    

    
    J Laryngol Otol

15. ZHAO P, Zhou Y, Li J
    Primary laryngeal lymphoma in China: a retrospective study of the last 25 years.
    J Laryngol Otol. 2019 Aug 19:1-4. doi: 10.1017/S0022215119001622.
    PubMed     Text format     Abstract available
    
    

    
    Leuk Lymphoma

16. DECKER DP, Egan PC, Zayac AS, Treaba DO, et al
    Treatment strategies and risk of central nervous system recurrence in high-grade B-cell and Burkitt lymphoma.
    Leuk Lymphoma. 2019 Aug 21:1-4. doi: 10.1080/10428194.2019.1654097.
    PubMed     Text format    
    
    
17. FUKUHARA N, Yamamoto G, Tsujimura H, Chou T, et al
    Retreatment with brentuximab vedotin in patients with relapsed/refractory classical Hodgkin lymphoma or systemic anaplastic large-cell lymphoma: a multicenter retrospective study.
    Leuk Lymphoma. 2019 Aug 22:1-5. doi: 10.1080/10428194.2019.1654100.
    PubMed     Text format    
    
    
18. GO H, Jang JY, Kim CW, Huh J, et al
    Identification of microRNAs modulated by DNA hypomethylating drugs in extranodal NK/T-cell lymphoma.
    Leuk Lymphoma. 2019 Aug 23:1-9. doi: 10.1080/10428194.2019.1654096.
    PubMed     Text format     Abstract available
    
    

    
    Leukemia

19. DESCH AK, Hartung K, Botzen A, Brobeil A, et al
    Genotyping circulating tumor DNA of pediatric Hodgkin lymphoma.
    Leukemia. 2019 Aug 20. pii: 10.1038/s41375-019-0541.
    PubMed     Text format     Abstract available
    
    

    
    N Engl J Med

20. RASHIDI A, Courville E
    Massive Splenomegaly.
    N Engl J Med. 2019;381:e11.
    PubMed     Text format    
    
    

    
    Oncol Rep

21. WANG X, Tan Y, Huang Z, Huang N, et al
    Disrupting myddosome assembly in diffuse large Bcell lymphoma cells using the MYD88 dimerization inhibitor ST2825.
    Oncol Rep. 2019 Aug 19. doi: 10.3892/or.2019.7282.
    PubMed     Text format     Abstract available
    
    
22. ZHANG R, Deng Q, Jiang YY, Zhu HB, et al
    Effect and changes in PD1 expression of CD19 CART cells from T cells highly expressing PD1 combined with reduceddose PD1 inhibitor.
    Oncol Rep. 2019;41:3455-3463.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

23. AKPA CA, Kleo K, Lenze D, Oker E, et al
    DZNep-mediated apoptosis in B-cell lymphoma is independent of the lymphoma type, EZH2 mutation status and MYC, BCL2 or BCL6 translocations.
    PLoS One. 2019;14:e0220681.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: